rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2007-2-16
|
pubmed:abstractText |
We analyzed the hematopoietic reconstitution and outcome of 508 patients with multiple myeloma (MM) with respect to the number of CD34+ cells reinfused at our center.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0902-4441
|
pubmed:author |
pubmed-author:BASAKN GNG,
pubmed-author:BreitkreutzIrisI,
pubmed-author:CremerFriedrich WFW,
pubmed-author:EgererGerlindeG,
pubmed-author:FruehaufStefanS,
pubmed-author:GoldschmidtHartmutH,
pubmed-author:HegenbartUteU,
pubmed-author:HerrmannDorisD,
pubmed-author:HoAnthony DAD,
pubmed-author:KlausJensJ,
pubmed-author:LowenthalRay MRM,
pubmed-author:MazitschekUtaU,
pubmed-author:MoehlerThomasT
|
pubmed:issnType |
Print
|
pubmed:volume |
78
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
21-8
|
pubmed:meshHeading |
pubmed-meshheading:17042762-Adult,
pubmed-meshheading:17042762-Aged,
pubmed-meshheading:17042762-Antigens, CD34,
pubmed-meshheading:17042762-Cohort Studies,
pubmed-meshheading:17042762-Dose-Response Relationship, Immunologic,
pubmed-meshheading:17042762-Female,
pubmed-meshheading:17042762-Graft Survival,
pubmed-meshheading:17042762-Hematopoiesis,
pubmed-meshheading:17042762-Hematopoietic Stem Cells,
pubmed-meshheading:17042762-Humans,
pubmed-meshheading:17042762-Male,
pubmed-meshheading:17042762-Middle Aged,
pubmed-meshheading:17042762-Multiple Myeloma,
pubmed-meshheading:17042762-Peripheral Blood Stem Cell Transplantation,
pubmed-meshheading:17042762-Platelet Count,
pubmed-meshheading:17042762-Prognosis,
pubmed-meshheading:17042762-Survival Rate,
pubmed-meshheading:17042762-Transplantation, Autologous,
pubmed-meshheading:17042762-Transplantation Conditioning,
pubmed-meshheading:17042762-Treatment Outcome
|
pubmed:year |
2007
|
pubmed:articleTitle |
Effect of CD34 cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.
|
pubmed:affiliation |
Department of Internal Medicine V, University Heidelberg, Heidelberg, Germany.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|